Oncology Institute posts Q1 2026 EPS -$0.02 (+90% YoY) on revenue $147.4M (+41% YoY), beating EPS and revenue estimates
- Q1 2026 net loss narrows to $2.5M, as reported by the company
- Company reaffirms 2026 guidance and projects Q2 2026 Adjusted EBITDA between $(1) million and $1 million
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.